GASTROINTESTINAL STROMAL TUMOR (GIST)
Clinical trials for GASTROINTESTINAL STROMAL TUMOR (GIST) explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMOR (GIST) trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMOR (GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for tough stomach cancer in early trial
Disease control OngoingThis first-in-human study tests an experimental oral drug called IDRX-42 in 278 adults with advanced gastrointestinal stromal tumors (GIST) that have spread or cannot be removed by surgery. The main goals are to check safety, find the right dose, and see if the drug can shrink tu…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE1 • Sponsor: IDRX, Inc., a wholly owned subsidiary of GSK, LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New surgery aims to remove stomach tumors without major incisions
Disease control ENROLLING_BY_INVITATIONThis study tests a new surgical method for removing non-cancerous or early cancerous growths (submucosal tumors) located where the stomach meets the esophagus. The technique combines two types of scopes (laparoscope and endoscope) with a special step to prepare the blood vessels …
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug cocktail aims to tackle tough stomach cancer
Disease control OngoingThis study tests a combination of two drugs, MEK162 and imatinib (Gleevec), in people with advanced gastrointestinal stromal tumor (GIST). The first part finds the safest dose, and the second part checks how well the combo shrinks tumors. About 75 participants will take part, inc…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Taiwan study hunts for hidden genetic clues in rare stomach cancer
Knowledge-focused OngoingThis study looks at the genetic makeup of a rare stomach cancer called gastrointestinal stromal tumor (GIST) in patients whose tumors lack common mutations. Researchers will analyze tumor samples from 50 people in Taiwan to find other genetic changes that might be treatable. The …
Matched conditions: GASTROINTESTINAL STROMAL TUMOR (GIST)
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC